Yahoo! Finance: Novel brain injury treatment tested in 1st human subject; drug conceived at UT Health San Antonio

Thursday, June 16, 2022

<p>James D. Lechleiter, PhD, professor of cell systems and anatomy at UT Health San Antonio, and Andrea Giuffrida, PhD, vice president for strategic industry ventures at UT Health San Antonio, were quoted in this story about the first human test of experimental brain injury medication conceived in laboratories at UT Health San Antonio. Read More</p>

Share This Story